Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial

BACKGROUND: Patients with high Gleason score, elevated prostate specific antigen (PSA) level, and advanced clinical stage are at increased risk for both local and systemic relapse. Recent data suggests higher radiation doses decrease local recurrence and may ultimately benefit biochemical, metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Konaka, Hiroyuki, Egawa, Shin, Saito, Shiro, Yorozu, Atsunori, Takahashi, Hiroyuki, Miyakoda, Keiko, Fukushima, Masanori, Dokiya, Takushi, Yamanaka, Hidetoshi, Stone, Nelson N, Namiki, Mikio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350387/
https://www.ncbi.nlm.nih.gov/pubmed/22439742
http://dx.doi.org/10.1186/1471-2407-12-110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350387/
https://www.ncbi.nlm.nih.gov/pubmed/22439742
http://dx.doi.org/10.1186/1471-2407-12-110

Ejemplares similares